[
  {
    "ts": null,
    "headline": "Junkiest Junk Is Offering a Warning Sign for Debt",
    "summary": "(Bloomberg) -- For much of the year, money managers have embraced optimism and snatched up corporate bonds, sending valuations to ever more expensive levels. Now, Wall Street titans are saying it’s time to focus on how bad things can get. Most Read from BloombergNY Private School Pleads for Donors to Stay Open After Declaring BankruptcyUAE’s AI University Aims to Become Stanford of the GulfNYC’s War on Trash Gets a Glam SquadChicago’s O’Hare Airport Seeks Up to $4.3 Billion of Muni DebtPacific C",
    "url": "https://finnhub.io/api/news?id=c66a483a5203aebf3d348a6b31edbfabd993e7e7703cecd977e25a1662e294b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748113200,
      "headline": "Junkiest Junk Is Offering a Warning Sign for Debt",
      "id": 134694247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- For much of the year, money managers have embraced optimism and snatched up corporate bonds, sending valuations to ever more expensive levels. Now, Wall Street titans are saying it’s time to focus on how bad things can get. Most Read from BloombergNY Private School Pleads for Donors to Stay Open After Declaring BankruptcyUAE’s AI University Aims to Become Stanford of the GulfNYC’s War on Trash Gets a Glam SquadChicago’s O’Hare Airport Seeks Up to $4.3 Billion of Muni DebtPacific C",
      "url": "https://finnhub.io/api/news?id=c66a483a5203aebf3d348a6b31edbfabd993e7e7703cecd977e25a1662e294b7"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost",
    "summary": "Pfizer Inc. (NYSE:PFE) has unveiled major advances in cancer research at the 2025 ASCO Annual Meeting, spotlighting robust five-year survival results for XTANDI (enzalutamide) combined with androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer. Data from the Phase 3 ARCHES trial show XTANDI plus ADT cuts the risk of death by 30%, with a […]",
    "url": "https://finnhub.io/api/news?id=c2966fb54d0485a5084f74487d432502d0c8cddfdb18c731567f96a31cc19c05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748098779,
      "headline": "Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost",
      "id": 134694418,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. (NYSE:PFE) has unveiled major advances in cancer research at the 2025 ASCO Annual Meeting, spotlighting robust five-year survival results for XTANDI (enzalutamide) combined with androgen deprivation therapy (ADT) in metastatic hormone-sensitive prostate cancer. Data from the Phase 3 ARCHES trial show XTANDI plus ADT cuts the risk of death by 30%, with a […]",
      "url": "https://finnhub.io/api/news?id=c2966fb54d0485a5084f74487d432502d0c8cddfdb18c731567f96a31cc19c05"
    }
  },
  {
    "ts": null,
    "headline": "Down 63%, Should You Buy the Dip on Pfizer?",
    "summary": "Pfizer has taken its lumps lately. It's time to wonder whether the stock can make a comeback.",
    "url": "https://finnhub.io/api/news?id=6a597f746900e6d68ec434bdefabd098beccad12e2358a5e8ec54d316e7222bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748090700,
      "headline": "Down 63%, Should You Buy the Dip on Pfizer?",
      "id": 134694419,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer has taken its lumps lately. It's time to wonder whether the stock can make a comeback.",
      "url": "https://finnhub.io/api/news?id=6a597f746900e6d68ec434bdefabd098beccad12e2358a5e8ec54d316e7222bb"
    }
  },
  {
    "ts": null,
    "headline": "Charting the Global Economy: Long-Term Bond Yields Soar Around the World",
    "summary": "(Bloomberg) -- Around the world, yields on longer-dated sovereign debt have soared as investors question the ability of governments to cover massive budget deficits.Most Read from BloombergNY Private School Pleads for Donors to Stay Open After Declaring BankruptcyUAE’s AI University Aims to Become Stanford of the GulfNYC’s War on Trash Gets a Glam SquadCan Frank Gehry’s ‘Grand LA’ Make Downtown Feel Like a Neighborhood?Chicago’s O’Hare Airport Seeks Up to $4.3 Billion of Muni DebtIn the US, 30-y",
    "url": "https://finnhub.io/api/news?id=d569bc16c6cd04d7f61600fa09ed7434474b8cf9e30c439ea3467ea724db4b47",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748077200,
      "headline": "Charting the Global Economy: Long-Term Bond Yields Soar Around the World",
      "id": 134694219,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- Around the world, yields on longer-dated sovereign debt have soared as investors question the ability of governments to cover massive budget deficits.Most Read from BloombergNY Private School Pleads for Donors to Stay Open After Declaring BankruptcyUAE’s AI University Aims to Become Stanford of the GulfNYC’s War on Trash Gets a Glam SquadCan Frank Gehry’s ‘Grand LA’ Make Downtown Feel Like a Neighborhood?Chicago’s O’Hare Airport Seeks Up to $4.3 Billion of Muni DebtIn the US, 30-y",
      "url": "https://finnhub.io/api/news?id=d569bc16c6cd04d7f61600fa09ed7434474b8cf9e30c439ea3467ea724db4b47"
    }
  },
  {
    "ts": null,
    "headline": "1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist",
    "summary": "Pfizer's attractive valuation and ultra-high dividend yield make it a great pick right now.  Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high.  When a stock plunges as much as Pfizer has, there must be a reason behind the decline.",
    "url": "https://finnhub.io/api/news?id=99fc9521f68ea0a02b6257443f374bd54cb8a72d3551e48896e76c2dd9229df3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748076660,
      "headline": "1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist",
      "id": 134694421,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer's attractive valuation and ultra-high dividend yield make it a great pick right now.  Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high.  When a stock plunges as much as Pfizer has, there must be a reason behind the decline.",
      "url": "https://finnhub.io/api/news?id=99fc9521f68ea0a02b6257443f374bd54cb8a72d3551e48896e76c2dd9229df3"
    }
  },
  {
    "ts": null,
    "headline": "U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result",
    "summary": "There's little doubt these pharmaceutical companies' costs will soon be rising at least a little.",
    "url": "https://finnhub.io/api/news?id=f719299cacc96fc5be15fbc21c37ddcc0b119b8362ed348a4ed92cbb30f31719",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748074260,
      "headline": "U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result",
      "id": 134694325,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "There's little doubt these pharmaceutical companies' costs will soon be rising at least a little.",
      "url": "https://finnhub.io/api/news?id=f719299cacc96fc5be15fbc21c37ddcc0b119b8362ed348a4ed92cbb30f31719"
    }
  }
]